It's interesting, sure. Still very early stage pre-clinical in the lab, basically in petri dishes. Maybe try further again and into mice next year ? Along with the other proposed mouse models in 2018. FWIW when ever people are banging on about "cure for cancer" is more hurt than good imo - and in petri-dishes that's not anything new, plenty of people / companies can cure cancer in a petri dish or test tube. PARP inhibitors are a hot space although we already knew that and they thought they would work synergistically with inhibitors like parp.
Further animal models should be interesting in 2018
Ann: PAT-DX1 Conjugated to Nanoparticles, Targets Tumors, page-122
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2053666 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3325244 | 5 |
View Market Depth
| Last trade - 16.12pm 19/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable